CStone Pharmaceuticals (FRA:PH4) Short-Term Debt : €0.00 Mil (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Short-Term Debt?

CStone Pharmaceuticals's Short-Term Debt for the quarter that ended in Jun. 2023 was €0.00 Mil.

CStone Pharmaceuticals's quarterly Short-Term Debt declined from Jun. 2022 (€4.18 Mil) to Dec. 2022 (€1.16 Mil) and declined from Dec. 2022 (€1.16 Mil) to Jun. 2023 (€0.00 Mil).

CStone Pharmaceuticals's annual Short-Term Debt declined from Dec. 2021 (€4.27 Mil) to Dec. 2022 (€1.16 Mil) but then increased from Dec. 2022 (€1.16 Mil) to Dec. 2023 (€13.61 Mil).

CStone Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for CStone Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Short-Term Debt Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

0.34

4.27

1.16

13.61

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial									4.27	4.18	1.16	-	13.61

CStone Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

CStone Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (FRA:PH4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (FRA:PH4) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

CSPHF:USA 02616:Hong Kong PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (FRA:PH4) Headlines

No Headlines